Encycle Therapeutics is a biopharmaceutical company exploiting proprietary technology that enables the rapid synthesis of macrocycles.
Employees: 1-10
Total raised: $2.14M
Founded date: 2012
Investors 2
| Date | Name | Website |
| - | adMare Bio... | admarebio.... |
| - | MaRS Inves... | marsiaf.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.09.2015 | - | $2.14M | - |
Mentions in press and media 2
| Date | Title | Description |
| 30.09.2015 | Daily funding roundup - September 30, 2015 | Avant scored $325M; NewStore raised $38M; PerfectServe landed $21M Molio, Inc., a Salt Lake City-based creative and media agency focused on building brands through YouTube, raised a $1 million credit facility. Square 1 Bank provided the fin... |
| 30.09.2015 | Encycle Therapeutics Completes CAD$2.85M Financing | Encycle Therapeutics, Inc., a Toronto, Canada-based drug discovery company, completed a CAD$2.85m financing. The round was led by Takeda Pharmaceutical Company, through its venture capital arm Takeda Ventures, Inc., with participation from ... |